Alignment between outcomes and minimal clinically important differences in the Dutch type 2 diabetes mellitus guideline and healthcare professionals’ preferences

Abstract To evaluate the clinical benefit of new medicines for type 2 diabetes mellitus (T2DM), the Dutch guideline committee T2DM in primary care established the importance of outcomes and minimal clinically important differences (MCIDs). The present study used an online questionnaire to investigate healthcare professionals’ opinions about the importance of outcomes and preferences for MCIDs. A total of 211 physicians, pharmacists, practice nurses, diabetes nurses, nurse practitioners and physician assistants evaluated the importance of mortality, macro‐ and microvascular morbidity, HbA1c, bo... Mehr ...

Verfasser: Dankers, Marloes
Nelissen‐Vrancken, Marjorie H. J. M. G.
Hart, Bertien H.
Lambooij, Anke C.
van Dijk, Liset
Mantel‐Teeuwisse, Aukje K.
Dokumenttyp: Artikel
Erscheinungsdatum: 2021
Reihe/Periodikum: Pharmacology Research & Perspectives ; volume 9, issue 3 ; ISSN 2052-1707 2052-1707
Verlag/Hrsg.: Wiley
Schlagwörter: General Pharmacology / Toxicology and Pharmaceutics / Neurology
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26690505
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://dx.doi.org/10.1002/prp2.750